Animal models for tumor progression (short review)

Area of Science:

• Oncology
• Cancer Biology
• Drug Development

Background:

• Tumor progression research has grown significantly, with a focus on selecting malignancy variants.
• Current models for studying neoplastic development and malignancy assays may not accurately reflect natural tumor progression.

Purpose of the Study:

• To critically evaluate existing models used in tumor progression research.
• To assess the advantages and disadvantages of various malignancy selection and testing models.
• To discuss the validity of these models for anti-cancer drug testing at different tumor progression stages.

Main Methods:

• Review and discussion of various tumor progression models.
• Evaluation of the strengths and weaknesses of each model.
• Analysis of model relevance to natural tumor progression and drug development.

Main Results:

• Identified limitations in current models for accurately simulating natural tumor progression.
• Highlighted discrepancies between in vitro/in vivo models and the in vivo reality of cancer development.
• Assessed the applicability of different models for evaluating anti-cancer therapeutics.

Conclusions:

• Existing models for studying tumor progression and malignancy variants require careful consideration of their limitations.
• The choice of model significantly impacts the relevance of findings for understanding cancer and testing anti-cancer drugs.
• Further development of more biologically relevant models is crucial for advancing cancer research and drug discovery.